GTx-134 is a dual inhibitor of insulin-like growth factor 1 receptor (IGF-1R) and insulin receptor (IR), exhibiting IC50 values of 97 nM and 187 nM, respectively. This compound effectively inhibits IGF-1R autophosphorylation and downstream Akt signaling, thereby interfering with the proliferation and survival of tumor cells. GTx-134 demonstrates broad-spectrum activity against multiple myeloma cell lines, inducing apoptosis in sensitive cells, and significantly reduces tumor growth in mouse models of myeloma. Its potential for synergistic effects with existing therapies makes GTx-134 a valuable reagent for high-risk myeloma research.
GTx-134 is a dual inhibitor of insulin-like growth factor 1 receptor (IGF-1R) and insulin receptor (IR), exhibiting IC50 values of 97 nM and 187 nM, respectively. This compound effectively inhibits IGF-1R autophosphorylation and downstream Akt signaling, thereby interfering with the proliferation and survival of tumor cells. GTx-134 demonstrates broad-spectrum activity against multiple myeloma cell lines, inducing apoptosis in sensitive cells, and significantly reduces tumor growth in mouse models of myeloma. Its potential for synergistic effects with existing therapies makes GTx-134 a valuable reagent for high-risk myeloma research.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
